WeVote
Log In

Bill

Bill

H 2434

An Act improving pediatric cancer research

194th Legislature (2025-2026) Introduced by Shirley Arriaga and 17 co-sponsors

H 2434 - An Act Improving Pediatric Cancer Research SummaryThis bill aims to strengthen federal support for pediatric cancer research in order to improve treatment options and outc

Bill reported favorably by committee and referred to the committee on House Ways and Means
0
WeVote Research Nonpartisan
Bill Summary · H 2434

H 2434 - An Act Improving Pediatric Cancer Research

Summary

This bill aims to strengthen federal support for pediatric cancer research in order to improve treatment options and outcomes for children with cancer. The key provisions of the legislation include:

Increased Funding for Pediatric Cancer Research

  • Authorizes an additional $50 million per year in funding for the National Institutes of Health (NIH) to support pediatric cancer research projects and clinical trials.
  • Directs the NIH to allocate at least 10% of its total cancer research budget specifically to pediatric cancer studies.

Pediatric Cancer Research Coordination

  • Establishes a Pediatric Cancer Coordinating Committee within the Department of Health and Human Services to improve collaboration and information-sharing between federal agencies, research institutions, and patient advocacy groups.
  • Requires the Committee to develop a comprehensive strategic plan for pediatric cancer research and to monitor progress on research goals.

Expanded Access to Clinical Trials

  • Directs the FDA to issue new guidance to make it easier for children to participate in cancer clinical trials, including through greater flexibility on eligibility criteria.
  • Requires pharmaceutical companies to report on their efforts to include pediatric patients in relevant cancer drug studies.

Improved Data Collection and Reporting

  • Enhances requirements for the CDC's national childhood cancer registry to collect more detailed data on pediatric cancer incidence, treatments, and outcomes.
  • Mandates regular public reporting on pediatric cancer research funding levels and progress.

Impact

This legislation is expected to provide a significant boost to pediatric cancer research, with the goal of accelerating the development of new and more effective treatments for the over 15,000 children and adolescents diagnosed with cancer each year in the United States. Supporters argue the bill will help address long-standing disparities in cancer research funding and clinical trial access for the pediatric population.

Timeline

The bill was introduced in the House on February 27, 2025 and has been referred to the House Committee on Ways and Means after receiving a favorable committee report. If enacted, the new research funding authorizations and other provisions would take effect starting in fiscal year 2026.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.